Abstract
Background and Aims : seq−1 peptide (CHLLVDFLQSLS) derived from the C-terminus segment of the cholesteryl-ester transfer protein (CETP), corresponds to the active component of therapeutic nasal vaccine HB-ATV-8, designed to prevent and control the processes of atherosclerosis and fatty liver disease. During our investigation, we have previously established in vivo (rabbit and pig models), the protective effect of vaccine HB- ATV-8 against the development of these two diseases.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
